Respiratory News and Research

RSS

Once-daily treatment with Alvesco (ciclesonide) in asthma patients has no effect on normal adrenal function

New data presented at the American Thoracic Society’s 2004 International Conference show that once-daily treatment with the investigational therapy Alvesco (ciclesonide) in mild-to-moderate asthma patients has no effect on normal adrenal function, as demonstrated by measurements of the hypothalamic-pituitary-adrenal (HPA)-axis.

24 May 2004

China commences first clinical test of SARS vaccine

The Xinhuanet Chinese news agency reports that four volunteers are in good health following injections of the world's first clinical test of a severe acute respiratory syndrome (SARS) vaccine.

23 May 2004

Health Canada to tackle human health impacts of air pollution

Health Minister Pierre Pettigrew today announced the Government of Canada is allocating $1 million over the next year to fund cutting-edge research on the human health impacts of air pollution in support of the Georgia Basin/Puget Sound International Airshed Strategy, one of three pilot projects under the Canada-United States Border Air Quality Strategy.

20 May 2004

FDA finalizes new rule on donor eligibility for human tissues and cells

FDA today published a final rule establishing donor eligibility criteria for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps) to help prevent the transmission of communicable disease when these products are transplanted.

20 May 2004

Dietary supplement reduces body fat mass in overweight adults by as much as nine percent

A study to be published in the June issue of The American Journal of Clinical Nutrition concludes that the dietary supplement, conjugated linoleic acid (CLA), reduces body fat mass in overweight, but otherwise healthy, adults by as much as nine percent.

20 May 2004

Canadian Statement to the World Health Assembly focuses on AIDS

The WHO's leadership is particularly important in the fight to combat HIV/AIDS. Last week, Canada bolstered its financial commitment to this effort with contributions of $100 million for WHO's '3 by 5 initiative', and $70 million to the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria. Canada and Canadians are proud to take these actions against HIV/AIDS.

19 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

Glucose metabolism could be used to selectively destroy cancer cells

Scientists have known for decades that cancer cells consume more glucose than normal cells. A longstanding assumption that the excess glucose metabolism was needed to make energy has not been borne out by research studies.

15 May 2004

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

Britannia Pharmaceuticals Limited announced today that U.S.-based Bertek Pharmaceuticals Inc., the branded subsidiary of Mylan Laboratories Inc has received approval from the Food and Drug Administration for APOKYN (apomorphine hydrochloride injection).

13 May 2004

CMS proposed rule that would increase payments to acute care hospitals

The Centers for Medicare & Medicaid Services (CMS) today issued a proposed rule that would increase payments to acute care hospitals for inpatient services in fiscal year 2005

11 May 2004

What's the fourth biggest killer in America? Over 51% of Americans don't know either

More than half of Americans (51 percent) have never even heard of a disease that is the fourth leading killer in this country, according to results of a nationwide survey released today by the National Women’s Health Resource Center (NWHRC).

11 May 2004

2 SARS patients in Beijing discharged from hospital

Xinhua reported today that there were no new cases of severe acute respiratory syndrome (SARS) over the past 24 hours in China and 2 SARS patients in Beijing were discharged from hospital.

11 May 2004

American Lung Association welcomes EPA nonroad diesel rule

The American Lung Association has welcomed the U.S. Environmental Protection Agency move to clean up heavy equipment and diesel fuel. The rule closes the loophole that left millions of engines ranging from small construction equipment, tractors and heavy equipment like bulldozers under regulated.

11 May 2004

Asthma program helps school children improve grades

Detroit public school children living with asthma may have fewer absences and improve their grades with the help of a new comprehensive asthma program.

10 May 2004

Chronic respiratory symptoms are prominent among Alaska Native children

Chronic respiratory symptoms are prominent among Alaska Native children in the Yukon-Kuskokwim delta (YK delta) region of Alaska, with symptoms varying greatly within the geographic location.

10 May 2004

The outbreak of SARS is under control in China's eastern province of Anhui

A labratory worker who was China's first SARS patient in the recent outbreak has fully recovered and has been discharged from hospital today as Chinese health officials claimed success in controlling the disease in eastern Anhui province.

10 May 2004

Study has found the Sars virus in sweat glands and the intestine

Pathologists from the First Military Medical University in Guangzhou, southern China, warn that if further research proves that Sars can be transmitted by these unexpected routes, the implications for public health are major.

7 May 2004

Female testosterone patch significantly increased satisfying sexual activity and desire

Data from a landmark Phase III safety and efficacy study of 562 women showed treatment with an investigational female testosterone patch significantly increased satisfying sexual activity and desire in patients with Hypoactive Sexual Desire Disorder (HSDD), who previously had both ovaries removed. HSDD is defined as a lack of sexual desire that causes a woman personal distress.

6 May 2004

Immtech signs agreement with CombinatoRx to test Immtech compounds as potential cancer treatment

Immtech International, Inc. announced today that it signed an agreement with CombinatoRx of Boston, Massachusetts to screen its lead aromatic cationic compounds, DB289 and DB75, for activity against various cancers.

5 May 2004

Hong Kong SARS update

Hong Kong has been free from Severe Acute Respiratory Syndrome (SARS) since 2 June 2003 and is a safe place to visit.

5 May 2004

Respiratory News and Research

Once-daily treatment with Alvesco (ciclesonide) in asthma patients has no effect on normal adrenal function

China commences first clinical test of SARS vaccine

Health Canada to tackle human health impacts of air pollution

FDA finalizes new rule on donor eligibility for human tissues and cells

Dietary supplement reduces body fat mass in overweight adults by as much as nine percent

Canadian Statement to the World Health Assembly focuses on AIDS

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Glucose metabolism could be used to selectively destroy cancer cells

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

CMS proposed rule that would increase payments to acute care hospitals

What's the fourth biggest killer in America? Over 51% of Americans don't know either

2 SARS patients in Beijing discharged from hospital

American Lung Association welcomes EPA nonroad diesel rule

Asthma program helps school children improve grades

Chronic respiratory symptoms are prominent among Alaska Native children

The outbreak of SARS is under control in China's eastern province of Anhui

Study has found the Sars virus in sweat glands and the intestine

Female testosterone patch significantly increased satisfying sexual activity and desire

Immtech signs agreement with CombinatoRx to test Immtech compounds as potential cancer treatment

Hong Kong SARS update

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News